Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06232044 · RECRUITING
Trial details
- NCT number
- NCT06232044
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-23
- Primary completion
- 2028-05-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.